Association between alendronate v.s raloxifene and esophageal diseases among patients with osteoporosis
碩士 === 中國醫藥大學 === 醫務管理學系碩士班 === 100 === Objective: Both alendronate and raloxifene have become the major treatment for osteoporosis in recent years. Nevertheless, the literatures show that both of them could result in acutely esophageal nociception in different degrees, and repeated esophageal nocic...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2012
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/06307173718037511456 |